Analysts have recently evaluated GoodRx Holdings and provided 12-month price targets. The average target is $4.16, accompanied by a high estimate of $6.00 and a low estimate of $2.75. This current ...
GoodRx's telemedicine service offers oral semaglutide for weight loss, with initial pricing of $149 for 1.5 mg and 4 mg doses, increasing to $199 for 4 mg after April 2026. Larger doses of oral ...
Surescripts is teaming up with Good Rx to surface key prescription discounts to consumers. | SAN FRANCISCO — Surescripts is ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is ...
Eligible patients can now get the Wegovy pill — the first oral GLP-1 treatment for weight management in adults — at Hy-Vee ...
TipRanks on MSN
GoodRx price target lowered to $2.60 from $3 at BofA
BofA analyst Allen Lutz lowered the firm’s price target on GoodRx (GDRX) to $2.60 from $3 and keeps an Underperform rating on the shares. Heading ...
Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to transform the medication experience and empower patients by bringing ...
Pharmacy discount company GoodRx on Aug. 5 partnered with Surescripts, a health information network focused on e-prescriptions, to provide real-time drug discount pricing in EHRs. Prescription cost ...
End-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment “GoodRx is scaling a consumer-first model for affordable GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results